new glp-1 drug America's Poison Centers Diabetes Patients Also Struggle to

Information supplied to their GLP-1 patients TGA is recommending that patients only fill their prescription for GLP-1 therapies if their doctor confirms that this is still the best treatment option for the specific patient

To ensure people currently taking dulaglutide and liraglutide can continue to access these medicines, new initiations are restricted to people with type 2 diabetes who are high-risk and have no other appropriate treatment options

Cardiovascular drugs and therapy

Obesity Reviews 2021;22:111

Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta

Secondary endpoints included the rate of patients with a weight loss of 10%, monthly headache days (MHD), the rate of patients with a 30% and 50% reduction in MHD, visual outcome parameters, and adverse events (AEs)